Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 3, 2005, Pages 293-298

  Shennan, Andrew ^a   Jones, Griff ^a   Hawken, Jennifer ^a   Crawshaw, Sarah ^a   Judah, Jeanette ^a   Senior, Victoria ^a   Marteau, Theresa ^a   Chinn, Susan ^a   Poston, Lucilla ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MONOCLONAL ANTIBODY;

ADULT; ANXIETY; ARTICLE; CIGARETTE SMOKING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL FIBRONECTIN TEST; FETUS; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PREDICTION; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK FACTOR; SCREENING TEST; UTERINE CERVIX CERCLAGE;

ADULT; ANXIETY; BIOLOGICAL MARKERS; CERVIX UTERI; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PRENATAL DIAGNOSIS; SURVIVAL ANALYSIS; VAGINA;

EID: 14644399189     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00420.x     Document Type: Article

References (41)

1. Department of Health. Statistical Bulletin: NHS Maternity Statistics, England: 2001-2002. London: DOH, 2003.
2. Cust AE, Darlow BA, Donogue DA. Outcomes for high risk New Zealand newborn infants in 1998-1999: a population based national study. Arch Dis Child Fetal Neonatal 2003;88:F15-F22.
3. Macfarlene A, Mugford M, Henderson J, Furtado A, Stevens J, Dunn A. Birth Counts: Statistics of Pregnancy and Childbirth. London: The Stationery Office, 2000 (Second Volume Tables).
4. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICURE Study: outcome to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106(4): 659-671.
5. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343(6):378-384 (August 10).
6. Roth S, Wyatt J, Baudin J, et al. Looking back in time: outcome of a national cohort of very preterm infants born in The Netherlands in 1983. Early Hum Dev 2000;59:175-191.
7. da Fonesca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomised placebo-controlled double blind study. Am J Obstet Gynecol 2003;188:419-424.
8. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361:983-988.
9. Althuisius S, Dekker G, Hummel P, Bekedam D, Kuik D, van Giejn HP. Cervical incompetence prevention randomisation cerclage trial (CIPRACT); effect of therapeutic cerclage with bed rest v bed rest only on cervical length. Ultrasound Obstet Gynecol 2002;20:163-167.
10. Creasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol 1980;55:692-695.
11. Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynaecol 1998;12:312-317.
12. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-1743.
13. Goldenberg RL, Iams JD, Mercer BM, et al. The Preterm Prediction Study: toward a multiple-marker test for spontaneous pre-term birth. Am J Obstet Gynecol 2001;185:643-651.
14. Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-674.
15. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The Preterm Prediction Study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:643-648.
16. Goldenberg RL, Iams JD, Mercer BM, et al. What we have learned about the predictors of pre-term birth. Semin Perinatol 2003;27:185-193.
17. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002;325:301-311.
18. Hobel C, Dunkel-Schetter C, Roesch S, Castro L, Arora C. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 1999;180:S257-S263.
19. Ruis RJ, Fullerton J, Dudley DJ. The interrelationships of maternal stress, endocrine factors and inflammation on gestational length. Obstet Gynecol Surv 2003;58:415-428.
20. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-306.
21. Scakett DL, Haynes RB, Guyatt GH, Tugwell P. Clincial Epidemiology, 2nd edition. Boston: Little, Brown and Company, 1991.
22. Teixeira JM, Fisk NM, Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 1999;318:153-157.
23. Sjostrom K, Valentin L, Thelin T, Marsal K. Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 1997;74:149-155.
24. Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med 1999;49:1571-1598.
25. Mamelle N, Segueilla M, Munoz F, Berland M. Prevention of preterm birth in patients with symptoms of preterm labor - the benefits of psychologic support. Am J Obstet Gynecol 1997;177:947-952.
26. Aghajafari F, Murphy K, Willan K, et al. Multiple courses of antenatal corticosteroids: a systematic review and metanalysis. Am J Obstet Gynecol 2001;185:1073-1080.
27. CESDI. Project 27/28. An Enquiry Into Quality of Care and Its Effect on the Survival of Babies Born at 27/28 Weeks. London: The Stationery Office, 2003.
28. Goepfert AR, Goldenberg RL, Mercer B, et al. The Preterm Prediction Study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. Am J Obstet Gynecol 2000;183:1480-1483.
29. Leeson SC, Maresh MJA, Martindale EA, et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol 1996;103:48-53.
30. Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175:178-181.
31. Nageotte MP, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994;170:20-25.
32. Morrison JC, Naef III RW, Botti JJ, Katz M, Belluomini JM, McLaughlin BN. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstst Gynecol 1996;87(5 Pt 1):649-655.
33. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342(20):1500-1507.
34. Watts DH, Krohn MA, Millier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79:351-357.
35. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990;75:622-626.
36. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-540.
37. Klebanoff MA, Carey C, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic trichomonas vaginalis infection. N Engl J Med 2001;345:487-493.
38. Odendaal HJ, Popov I, Schoeman J, Smithy M, Grove D. Preterm labour-is bacterial vaginosis involved? South Afr Med J 2002;92:231-234.
39. Andrews WW, Sibai BM, Thom EA, et al. Randomised clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynaecol 2003;101:847-855.
40. Goldenberg RL, Klebanoff M, Carey JC, MacPherson C. Metronidazole treatment of women with positive fetal fibronectin test result. Am J Obstet Gynecol 2001;185:485-496.
41. Groom KM, Bennett PR, Poston L, Shennan AH. Antimicrobials in prevention of prematurity. Am J Obstet Gynecol 2002;186:1106-1107.